Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
- 12 resultaten
Zoekresultaten
-
2023
Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies
Mascart, F., Hites, M., Watelet, E., Verschelden, G., Meuris, C., Doyen, J-L., Praet, A. V., Godefroid, A., Petit, E., Singh, M., Locht, C. & Corbière, V., 8 mrt 2023, In: Journal of clinical medicine. 12, 6, 12 blz., 2127.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)6 Downloads (Pure) -
Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools
Verschelden, G., Noeparast, M., Vandervore, L., Stoefs, A., Olbrecht, M., Van Honacker, E., Vandamme, K., Vandoorslaer, K., Demuyser, T., Pierard, D. & Wybo, I., 29 nov 2023, In: Frontiers in Microbiology. 14, 2023, 9 blz., 1322180.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)31 Downloads (Pure) -
2022
Optimization of the Transwell® assay for the analysis of neutrophil chemotaxis using flow cytometry to refine the clinical investigation of immunodeficient patients
Lauwers, M., Verschelden, G., Boero, C., Baleine, M., Kerrels, V. & Cantinieaux, B., mei 2022, In: Clinical Immunology. 238, 108994.Onderzoeksoutput: Article › peer review
2 Citaten (Scopus) -
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
DisCoVeRy Study Group, Ader, F., Bouscambert-Duchamp, M., Hites, M., Peiffer-Smadja, N., Poissy, J., Belhadi, D., Diallo, A., Lê, M-P., Peytavin, G., Staub, T., Greil, R., Guedj, J., Paiva, J-A., Costagliola, D., Yazdanpanah, Y., Burdet, C. & Mentré, F., feb 2022, In: The Lancet Infectious Diseases. 22, 2, blz. 209-221 13 blz.Onderzoeksoutput: Article › peer review
Open Access247 Citaten (Scopus) -
Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection
Poncelet, A., Verschelden, G., Colard, M., Hildebrandt, M., Yin, N., Michel, C., Grimaldi, D. & De Wilde, V., 1 jan 2022, In: Leuk Lymphoma. 63, 1, blz. 253-255 3 blz.Onderzoeksoutput: Article › peer review
1 Citaat (Scopus) -
2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
Declercq, J., Van Damme, K. F. A., De Leeuw, E., Maes, B., Bosteels, C., Tavernier, S. J., De Buyser, S., Colman, R., Hites, M., Verschelden, G., Fivez, T., Moerman, F., Demedts, I. K., Dauby, N., De Schryver, N., Govaerts, E., Vandecasteele, S. J., Van Laethem, J., Anguille, S., van der Hilst, J. & 23 anderen, , dec 2021, In: The Lancet Respiratory Medicine. 9, 12, blz. 1427-1438 12 blz.Onderzoeksoutput: Article › peer review
Open Access96 Citaten (Scopus) -
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: An observational study
Verschelden, G., Noeparast, M., Noparast, M., Goossens, M. C., Lauwers, M., Cotton, F., Michel, C., Goyvaerts, C. & Hites, M., nov 2021, In: International Immunopharmacology. 100, 108163.Onderzoeksoutput: Article › peer review
Open Access11 Citaten (Scopus) -
Presumed Urinary Tract Infection in Patients Admitted with COVID-19: Are We Treating Too Much?
Van Laethem, J., Wuyts, S., Pierreux, J., Seyler, L., Verschelden, G., Depondt, T., Meuwissen, A. M. Y., Lacor, P., Pierard, D. & Allard, S., 6 dec 2021, In: Antibiotics (Basel). 10, 12, 1493.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)66 Downloads (Pure) -
2020
Mazelen: belang van vroegtijdige diagnostiek tijdens de prodromale fase
Reyskens, M., De Geyter, D., Mertens, R., Daelemans, S., Verschelden, G., Meuwissen, A. M. Y. & Lacor, P., 2020, In: Tijdschrift voor Geneeskunde. 76, 18, blz. 912-919 8 blz.Onderzoeksoutput: Article › peer review
-
2018
Significant response to dabrafenib in a patient with Erdheim-Chester disease with BRAFV600E mutation
Verschelden, G., Van Laethem, J., Velkeniers, B., Ilsen, B., Noeparast, A. & De Grève, J., 29 jun 2018, In: Archives of Internal Medicine. 128, 6, blz. 386-388 3 blz.Onderzoeksoutput: Article › peer review
Open Access7 Citaten (Scopus) -
2016
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
Noeparast, A., Teugels, E., Giron, P., Verschelden, G., De Brakeleer, S., Decoster, L. & De Grève, J., 26 aug 2016, In: Oncotarget. 8, 36, blz. 60094-60108 15 blz.Onderzoeksoutput: Article › peer review
79 Citaten (Scopus) -
2015
Leiomyosarcoom van de vena cava inferior
Verschelden, G., Van Eetvelde, E., Djedaïmi, H. & De Grève, J., 2015, In: Tijdschr Geneesk. 71, 9, blz. 615-621 7 blz.Onderzoeksoutput: Article › peer review